Key result
Blood aspirated from the culprit coronary artery contained significantly higher levels of IL-6 (P<0.001), MMP-1 (P<0.001), and MMP-13 (P<0.05) compared to peripheral blood in patients with AMI.
Why the study?
Are levels of matrix metalloproteinases and interleukin-6 elevated in the culprit coronary artery compared to peripheral blood in patients with acute myocardial infarction?
Observational (n=122)
Are levels of matrix metalloproteinases and interleukin-6 elevated in the culprit coronary artery compared to peripheral blood in patients with acute myocardial infarction?
p-value: p=<0.001
Levels of MMP-1, MMP-13, and IL-6 are significantly higher in the culprit coronary artery than in peripheral blood during the early stages of acute myocardial infarction, suggesting their local involvement in plaque instability.
No takes yet. Share an insight, caveat, or question.
May mark local drivers of plaque instability in AMI; extends systemic biomarker data but leaves open therapeutic implications.
Suzuki et al. (2008) conducted an observational in Acute myocardial infarction (n=122). Culprit coronary artery blood vs. Peripheral blood was evaluated on Serum levels of IL-6, MMP-1, and MMP-13 (p=<0.001). Blood aspirated from the culprit coronary artery contained significantly higher levels of IL-6 (P<0.001), MMP-1 (P<0.001), and MMP-13 (P<0.05) compared to peripheral blood in patients with AMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: